Clinical trial Recruiting at 1 site Observational

Registry of cancer patients treated with hyperthermia

Official title: Prospektive Hyperthermie-Datenbank Bei Krebspatienten (HTRegister)

Run by Charite University, Berlin, Germany · NCT05993910 · Data updated 2026-11-12

This study is collecting information from cancer patients treated with heat therapy to see how well it works alongside regular treatments and how it affects their health and survival.

More Breast Cancer trials

Quick facts

Study typeObservational
SexAll
Enrollment1000 (estimated)
SponsorCharite University, Berlin, Germany
Academic / other
Drugs / interventionschemotherapy, radiation
Locations2 sites (Berlin and 1 other locations)
StatusRecruiting
StartedNovember 1, 2014
Main results expectedOctober 31, 2028
Study endsOctober 31, 2028
Registry record updatedAugust 15, 2023
Trial IDNCT05993910 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include cancer patients who are receiving hyperthermia as part of their treatment regimen.

Probably not a fit

Patients with contraindications to hyperthermia, such as certain metal implants or mental health conditions that impair study participation, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry collects data on cancer patients at Charité who are treated with hyperthermia alongside standard oncological therapies. The study aims to evaluate the therapeutic use of hyperthermia, tracking patient outcomes such as complications, disease status, and survival rates. Additionally, patients may participate in translational research to identify prognostic factors related to their response to hyperthermia treatment. A total of 1000 patients will be included in this registry to provide comprehensive insights into the effectiveness and safety of hyperthermia in cancer care.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of hyperthermia's role in cancer treatment, potentially improving patient outcomes.

How similar studies have gone: While the use of hyperthermia in cancer treatment has been explored, this registry approach is relatively novel and aims to systematically document outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Contrazeption with female patients at the capable of bearing children age
* Written agreement is present (DvH, ICH-GCP)
* Patients, who participate at the same time in a interventional study, can nevertheless in this register study participate if this none Exclusion criterion for the interventional study represents.
* With children must the treatment with one of the GPOH agreed Pattern take place

Exclusion Criteria:

* Exclusion criteria for the hyperthermia (such as hip prosthesis in the therapeutic area, metal implants/marker, patients with cardiac pacemakers)
* mental disease, what the proper study participation does not allow.

Where it's running

  • Clinic for Radio - Oncology and Radiotherapy
    Berlin, Germany
    Recruiting
  • Clinic for Radio - Oncology and Radiotherapy
    Berlin, Germany
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.